Open AccessPulmonary toxicity following bleomycin use: A single-center experience
Author(s) -
Irappa Madabhavi,
Gaurang Modi,
Apurva Patel,
Asha Anand,
Harsha Panchal,
Sonia Parikh
Publication year - 2017
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.204887
Subject(s) - medicine , bleomycin , pulmonary toxicity , interstitial lung disease , dlco , asymptomatic , etoposide , bronchiectasis , dacarbazine , abvd , lung cancer , vinblastine , surgery , lung , vincristine , chemotherapy , diffusing capacity , cyclophosphamide , lung function
Bleomycin-induced pulmonary (BIP) toxicity is a notorious entity and cropped up in roughly 10% of cases. The aim of the study is to evaluate BIP at our tertiary care cancer center.